2026-10-10T04:10:41Z https://api.figshare.com/v2/oai

oai:figshare.com:article/34041093 2026-10-01T07:23:24Z category_37339 category_37363 category_37366 category_37375 portal_1012 item_type_6 month_year_10_2026

Supplementary Table S1 from Intratumoral Immune Heterogeneity Drives Divergent Outcomes to PD-(L)1 Blockade in Lung Cancer Laura Cipriani (19770895) Davide Mascolo (25154859) Stefano Scalera (19770889) Giulia Bon (9758057) Giulia Schiavoni (19770898) Antonella Palmese (25154862) Irene Terrenato (19770901) Maurizio Fanciulli (18889653) Ludovica Ciuffreda (19770904) Francesca De Nicola (19770907) Federico Bartoccini (25154865) Aldo Palange (25154868) Enzo Gallo (25154871) Edoardo Pescarmona (25154874) Simonetta Buglioni (20887699) Daniele Marinelli (18329934) Marco Mazzotta (25154877) Alessandro Di Federico (15561473) Ruggero De Maria (17779203) Giovanni Blandino (22955865) Biagio Ricciuti (14951247) Wael Salem Zrafi (25154880) Lodovica Zullo (14946796) Yohann Loriot (15123021) Mihaela Aldea (15115874) Benjamin Besse (15061674) Federico Cappuzzo (16041854) Marcello Maugeri-Saccà (19770913) Cancer Immuno-oncology Clinical Research and Trials Methods and Technology Computational Methods Artificial intelligence & machine learning Immunotherapy Checkpoint blockade Lung Cancer Precision Medicine <p>Baseline characteristics of patients included in clinical cohort A.</p> 2026-10-01T00:00:00Z Text Journal contribution 10.1158/1078-0432.34041093 https://figshare.com/articles/journal_contribution/Supplementary_Table_S1_from_Intratumoral_Immune_Heterogeneity_Drives_Divergent_Outcomes_to_PD-_L_1_Blockade_in_Lung_Cancer/34041093 CC BY